(Q45935444)

English

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.

scientific article published on 29 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Fotios Loupakis

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Chiara Cremolini

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Alfredo Falcone

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

N B Volz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S Stintzing

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

W Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Y Ning

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

T Wakatsuki

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

R E El-Khoueiry

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

J E Li

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Kardosh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

S J Scherer

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

H-J Lenz

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

29 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

69-76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069475%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

https://scigraph.springernature.com/pub.10.1038/tpj.2014.40

0 references

Normalization of the vasculature for treatment of cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Comprehensive molecular characterization of human colon and rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Markers of response for the antiangiogenic agent bevacizumab

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

The role of pericytes in blood-vessel formation and maintenance

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

A role for VEGF as a negative regulator of pericyte function and vessel maturation

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Regulation of Ras signaling specificity by protein kinase C.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Molecular predictors of response to antiangiogenesis therapies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

F-SNP: computationally predicted functional SNPs for disease association studies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Annotation of functional variation in personal genomes using RegulomeDB

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

High-resolution mapping of expression-QTLs yields insight into human gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Common regulatory variation impacts gene expression in a cell type-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

The effect of RGS12 on PDGFbeta receptor signalling to p42/p44 mitogen activated protein kinase in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.40

21 January 2018

Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features

1 reference

https://pubmed.ncbi.nlm.nih.gov/25069475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/25069475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle

1 reference

https://pubmed.ncbi.nlm.nih.gov/25069475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45935444&oldid=1424147763"